ARTICLE | Company News
SciClone, Zensun sales and marketing update
May 27, 2013 7:00 AM UTC
Zensun granted SciClone exclusive rights in China to commercialize Neucardin. The recombinant human neuregulin 1 (rhNRG1) injection has completed six Phase II trials in patients with chronic heart f...